• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    10.61 Down 0.45(4.07%) Jan 28, 4:00PM EST
    |After Hours : 10.61 0.00 (0.00%) Jan 28, 4:38PM EST
    Add to Portfolio
    Prev Close:11.06
    Open:11.12
    Bid:N/A
    Ask:12.74 x 100
    1y Target Est:17.45
    Beta:4.82
    Next Earnings Date:18-Feb-15BCRX Earnings announcement
    Day's Range:10.50 - 11.32
    52wk Range:7.29 - 14.62
    Volume:551,173
    Avg Vol (3m):858,053
    Market Cap:762.47M
    P/E (ttm):N/A
    EPS (ttm):-0.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BCRX

    Comparison

    Symbol% ChgMkt Cap
    BCRXDown 4.07%762.47M
    GSKDown 0.38%108.16B
    RHHBYDown 3.45%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):42.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.90

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback